ResMed Inc.

NYSE:RMD

Market Cap

USD 40.10 B

Share Price

USD 273.50

Avg Daily Volume

980,836

Change (1 day)

0.05%

Change (1 year)

32.64%

Change (YTD)

19.59%

ResMed Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2025: 31.83%

ResMed Inc. EBIT Margin is 31.83% for the Trailing 12 Months (TTM) ending March 31, 2025, a 11.08% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • ResMed Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was 28.66%, a 2.70% change year over year.
  • ResMed Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was 27.90%, a 0.10% change year over year.
  • ResMed Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was 27.87%, a -1.89% change year over year.
  • ResMed Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was 28.41%, a 19.77% change year over year.
Key Data
Date EBIT Margin EBITDA Margin Net Income Margin EBT Margin